Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024

The outbreak of the coronavirus pandemic illustrates the inherent risks and uncertainties that are prevalent in the operation of complex and global business, as seen in the pharmaceutical industry. The coronavirus pandemic also illustrates the need for companies to have empirical systems in place to act quickly to mitigate the effects of such events when they do occur. This white paper provides a ...

The 2018 Congressional midterm elections are over after a bitter political fight. The voters have spoken. We are back to divided government, with Democrats controlling the House, and Republicans expanding their majority in the Senate. Will there be bipartisan collaboration or political conflict and policy immobilism? This paper provides a detailed analysis why the US pharma industry, specifically ...

Globally, healthcare continues to focus on treating disease. More reactive ‘sick care’ than proactive ‘healthcare’! This approach basically leads to intervention only when the health of any person reaches a critical stage, resulting in costly clinical interventions and hospitalizations. Inefficiencies in the delivery of healthcare further contribute to spiraling costs. The unsustainable economic ...